Why the study?
Is a high sCD40L level at admission associated with increased in-hospital and 1-year all-cause mortality in patients with STEMI undergoing primary PCI?
Population
Patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Design
Cohort
Follow-up
1 year
Authors
Loading...
May refine post-PCI risk stratification in STEMI; hypothesis-generating and requires prospective validation before practice change.
Is a high sCD40L level at admission associated with increased in-hospital and 1-year all-cause mortality in patients with STEMI undergoing primary PCI?
Elevated sCD40L at admission may serve as a prognostic biomarker for short- and long-term mortality in STEMI patients treated with primary PCI.
Püşüroğlu et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: